Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Nov 3;31(1):102-105.
doi: 10.1016/j.joco.2018.10.003. eCollection 2019 Mar.

Hormone replacement therapy in Leber's hereditary optic neuropathy: Accelerated visual recovery in vivo

Affiliations
Case Reports

Hormone replacement therapy in Leber's hereditary optic neuropathy: Accelerated visual recovery in vivo

Michele Fantini et al. J Curr Ophthalmol. .

Abstract

Purpose: To report an accelerated course of visual recovery in a case of Leber's hereditary optic neuropathy (LHON) following treatment with idebenone and hormone replacement therapy (HRT). We hereby demonstrate the clinical utility of estrogen's protective role in LHON in vivo.

Methods: We present a case of LHON in a menopausal woman carrying the 10197 mitochondrial DNA (mtDNA) mutation, who experienced loss of vision shortly after discontinuing her estrogen replacement regimen. Functional visual outcomes are reported following treatment with idebenone and HRT.

Results: The patient exhibited an accelerated course of visual recovery, experiencing improvement in vision as early as one month and complete reversal of vision loss by eight months post-therapy.

Conclusion: Idebenone treatment combined with HRT may have a synergistic effect in enhancing cellular bioenergetics and may explain the patient's accelerated visual improvement.

Keywords: Accelerated visual improvement; Hormone replacement therapy; Leber's hereditary optic neuropathy; Mitochondrial disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A, B) Humphrey visual field (HVF) 24-2 maps of the visual field examination on initial presentation, revealing significant cecocentral scotomas in the left and right eye, respectively. (C, D) Depict total deviation of the visual field examination on initial presentation in the left and right eye, respectively. Mean deviation: –15.66 dB OS, –18.25 dB OD.
Fig. 2
Fig. 2
(A, B) Humphrey visual field (HVF) 30-2 maps of the visual field examination at two months, revealing mild decrease in cecocentral scotomas in the left and right eye, respectively. (C, D) depict total deviation of the visual field examination on initial presentation in the left and right eye, respectively. Mean deviation: −8.11 dB OD, −13.14 dB OS.
Fig. 3
Fig. 3
(A, B) Humphrey visual field (HVF) 30-2 maps of the visual field examination at eight months, revealing further decrease of the scotomas in the left and right eye, respectively. (C, D) depict less total deviation of the visual field examination on second visit in the left and right eye, respectively. Mean deviation: −4.56 dB OD, −6.61 dB OS.

References

    1. Riordan-Eva P., Sanders M.D., Govan G.G. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain. 1995;118(Pt 2):319–337. - PubMed
    1. Carelli V., Ross-Cisneros F., Sadun A.A. Mitochondrial disfunction as cause of optic neuropathies. Prog Retin Eye Res. 2004;23(1):53–89. - PubMed
    1. Sadun A.A., Carelli V., Salomao S.R. A very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy. Trans Am Ophthalmol Soc. 2002;100:169–178. Discussion 178–9. - PMC - PubMed
    1. De Marinis M. Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation. J Neurol. 2001;248(9):818–819. - PubMed
    1. Giordano C., Montopoli M., Perli E. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain. 2011;134(Pt 1):220–234. - PMC - PubMed

Publication types